A clinical-stage biotechnology company developing conjugate vaccines aimed at preventing serious bacterial infections. Its pipeline is focused on next‑generation pneumococcal vaccines designed to provide broader strain coverage than existing products, with multiple candidates in clinical development...
3 members of Congress have disclosed 6 trades in Vaxcyte, Inc. (PCVX), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-04-28 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-04-15 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-04-14 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-03-05 | Jefferson Shreve | sell | $15K – $50K |
| 2022-12-12 | Christopher L. Jacobs | sell | $1K – $15K |
| 2022-11-08 | Christopher L. Jacobs | buy | $1K – $15K |